JAK–STAT signalling controls cancer stem cell properties including chemotherapy resistance in myxoid liposarcoma

Myxoid liposarcoma (MLS) shows extensive intratumoural heterogeneity with distinct subpopulations of tumour cells. Despite improved survival of MLS patients, existing therapies have shortcomings as they fail to target all tumour cells. The nature of chemotherapy‐resistant cells in MLS remains unknow...

Descripción completa

Detalles Bibliográficos
Autores principales: Dolatabadi, Soheila, Jonasson, Emma, Lindén, Malin, Fereydouni, Bentolhoda, Bäcksten, Karin, Nilsson, Malin, Martner, Anna, Forootan, Amin, Fagman, Henrik, Landberg, Göran, Åman, Pierre, Ståhlberg, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Molecular Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590236/
https://www.ncbi.nlm.nih.gov/pubmed/30650179
http://dx.doi.org/10.1002/ijc.32123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590236/
https://www.ncbi.nlm.nih.gov/pubmed/30650179
http://dx.doi.org/10.1002/ijc.32123

Ejemplares similares